Apogee Therapeutics, Inc.
APGEDelisted Sep 3, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001974640
Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 288 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Apogee Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 139
- +1 vs. Q2 2024
- Shares held
- 56.1M
- +4.68M (+9.1%) vs. Q2 2024
- Total value
- $3.29B
- +$1.27B (+62.7%) vs. Q2 2024
- New holders
- 26
- 47 more added
- Sold out
- 25
- 46 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APGE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 288 | $8.93B |
| Q1 2026 | 224 | $6.64B |
| Q4 2025 | 207 | $5.27B |
| Q3 2025 | 174 | $2.37B |
| Q2 2025 | 183 | $2.51B |
| Q1 2025 | 169 | $2.30B |
| Q4 2024 | 158 | $2.62B |
| Q3 2024 | 139 | $3.29B |
| Q2 2024 | 139 | $2.13B |
| Q1 2024 | 139 | $3.52B |
| Q4 2023 | 85 | $1.16B |
| Q3 2023 | 73 | $848.7M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Apogee Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vestal Point Capital, LP | 136,500 | $8.02M | 0.63% | +136,500 | New |
| Avidity Partners Management LP | 154,000 | $9.05M | 0.46% | −333,000−68.4% | Reduced |
| Goldman Sachs Group Inc | 157,457 | $9.25M | 0.00% | −179,696−53.3% | Reduced |
| Boxer Capital, LLC | 179,000 | $10.5M | 0.52% | +179,000 | New |
| Two Sigma Investments, LP | 199,308 | $11.7M | 0.03% | −102,914−34.1% | Reduced |
| Morgan Stanley | 238,270 | $14.0M | 0.00% | +3,490+1.5% | Added |
| Charles Schwab Investment Management Inc | 280,428 | $16.5M | 0.00% | +41,686+17.5% | Added |
| Commodore Capital LP | 290,000 | $17.0M | 1.06% | 00.0% | Unchanged |
| Bank of America Corp | 299,472 | $17.6M | 0.00% | −50,084−14.3% | Reduced |
| Northern Trust Corp | 306,549 | $18.0M | 0.00% | −4,654−1.5% | Reduced |
| Frontier Capital Management Co LLC | 311,316 | $18.3M | 0.17% | +311,316 | New |
| Jennison Associates LLC | 312,611 | $18.4M | 0.01% | +6,533+2.1% | Added |
| Victory Capital Management Inc | 346,358 | $20.3M | 0.02% | +190,092+121.6% | Added |
| Barclays PLC | 365,046 | $21.4M | 0.01% | +287,243+369.2% | Added |
| Jefferies Financial Group Inc. | 369,197 | $21.7M | 0.35% | +189,120+105.0% | Added |
| OrbiMed Advisors LLC | 379,130 | $22.3M | 0.41% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 469,557 | $27.6M | 0.01% | +458,157+4,018.9% | Added |
| Waypoint Capital Advisors, LLC | 627,089 | $36.8M | 7.84% | +627,089 | New |
| Affinity Asset Advisors, LLC | 664,198 | $39.0M | 6.05% | −172,085−20.6% | Reduced |
| Paradigm Biocapital Advisors LP | 701,817 | $41.2M | 1.44% | +371,817+112.7% | Added |
| Point72 Asset Management, L.P. | 707,268 | $41.5M | 0.14% | +438,036+162.7% | Added |
| Price T Rowe Associates Inc | 758,081 | $44.5M | 0.01% | −10,140−1.3% | Reduced |
| Franklin Resources Inc | 860,989 | $48.1M | 0.01% | −144,481−14.4% | Reduced |
| Geode Capital Management, LLC | 823,839 | $48.4M | 0.00% | +82,978+11.2% | Added |
| Woodline Partners LP | 976,155 | $57.3M | 0.48% | +229,996+30.8% | Added |
| Deep Track Capital, LP | 1,000,000 | $58.7M | 1.88% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 1,194,363 | $70.2M | 0.02% | +62,093+5.5% | Added |
| State Street Corp | 1,411,639 | $82.9M | 0.00% | −149,723−9.6% | Reduced |
| Braidwell LP | 1,643,226 | $96.5M | 2.74% | −748,816−31.3% | Reduced |
| Ra Capital Management, L.P. | 1,961,863 | $115.2M | 1.33% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 2,015,007 | $118.4M | 2.54% | −90,629−4.3% | Reduced |
| Fairmount Funds Management LLC | 2,048,647 | $120.3M | 9.76% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,127,042 | $124.9M | 0.00% | +156,722+8.0% | Added |
| Driehaus Capital Management LLC | 2,533,607 | $148.8M | 1.28% | +415,737+19.6% | Added |
| RTW Investments, LP | 2,712,096 | $159.3M | 2.31% | 00.0% | Unchanged |
| BlackRock, Inc. | 2,975,917 | $174.8M | 0.00% | +2,975,917 | New |
| Wellington Management Group LLP | 4,814,400 | $282.8M | 0.05% | +1,267,451+35.7% | Added |
| FMR LLC | 7,502,482 | $440.7M | 0.03% | −3,3930.0% | Reduced |
| VR Adviser, LLC | 8,493,321 | $498.9M | 26.13% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −329,000−100.0% | Sold out |
| First Turn Management, LLC | 0 | $0 | 0.00% | −318,327−100.0% | Sold out |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −156,204−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −116,318−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −87,201−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −78,000−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −58,400−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −43,458−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −36,928−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −30,178−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −17,930−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −15,745−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −12,121−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −11,535−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −10,312−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −9,500−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −6,437−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −5,100−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −426−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −305−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |